Citadel Advisors’s OmniAb OABI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$19.8K Sell
12,600
-13,400
-52% -$24.2K ﹤0.01% 12673
2025
Q4
$48.1K Sell
26,000
-200
-0.8% -$348 ﹤0.01% 12054
2025
Q3
$41.9K Buy
+26,200
New +$47.9K ﹤0.01% 12274
2025
Q2
Sell
-1,000
Closed -$2.4K 14300
2025
Q1
$2.4K Sell
1,000
-9,100
-90% -$29.8K ﹤0.01% 14043
2024
Q4
$35.8K Buy
10,100
+4,700
+87% +$18.6K ﹤0.01% 12719
2024
Q3
$22.8K Buy
5,400
+4,400
+440% +$19K ﹤0.01% 12680
2024
Q2
$3.75K Sell
1,000
-8,000
-89% -$36.5K ﹤0.01% 13554
2024
Q1
$48.8K Sell
9,000
-8,900
-50% -$51.3K ﹤0.01% 12194
2023
Q4
$110K Buy
17,900
+10,600
+145% +$52.1K ﹤0.01% 10809
2023
Q3
$37.9K Sell
7,300
-15,600
-68% -$83.3K ﹤0.01% 12058
2023
Q2
$115K Buy
22,900
+1,720
+8% +$6.97K ﹤0.01% 10720
2023
Q1
$77.9K Sell
21,180
-8,720
-29% -$32.9K ﹤0.01% 11598
2022
Q4
$108K Buy
+29,900
New +$157K ﹤0.01% 11114

Other funds holding OABI

Citadel Advisors's OABI Position: Q1 2026 in Review

Citadel Advisors reduced its OmniAb (OABI) stake by 20% in Q1 2026, selling an estimated $102K and leaving 228,684 shares worth $359K. The position accounts for ﹤0.01% of the portfolio, ranked #10061.

Citadel Advisors first reported a position in OABI in Q4 2021 and has held it in 16 quarters since. The position peaked at $13.3M in Q4 2021. 128 funds tracked by Wall St. Rank hold OABI as of Q1 2026.

  • Citadel Advisors held 228,684 shares of OmniAb worth $359K as of Q1 2026.
  • Citadel Advisors sold 56,450 OmniAb shares in Q1 2026, an estimated $102K.
  • OmniAb made up ﹤0.01% of Citadel Advisors's portfolio in Q1 2026, its #10061 holding.
  • Citadel Advisors first reported a position in OmniAb in Q4 2021 and has held it in 16 quarters since.
  • Citadel Advisors's OmniAb position peaked at $13.3M in Q4 2021.
  • 128 funds tracked by Wall St. Rank held OmniAb as of Q1 2026.

Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.